<!DOCTYPE html>
<html>
	<head>
		<title>A Collection of Adaptive Design Software</title>
		<!-- link to main stylesheet -->
		<link rel="stylesheet" type="text/css" href="/css/main/css">
	</head>
	<body>
		<nav>
    		<ul>
        		<li><a href="/">Home</a></li>

    		</ul>
		</nav>
		<div class="container">
    		<div class="blurb">
        		<h1>Adaptive design software</h1>
			<p>Following the FDA's <a href="https://www.fda.gov/regulatory-information/search-fda-guidance-documents/adaptive-design-clinical-trials-drugs-and-biologics-guidance-industry">guidance document</a> 
				on the appropriate use of adaptive designs for clinical trials to provide evidence of the effectiveness and safety of a drug or biologic, I have assembled a collection of SAS and R code on the following topics: </p>
				
			
    <a href="/SSR" class="catalogue-item">
      <div>
        <h1 class="catalogue-title">Sample size recalculation</h1> </a>
        <div class="catalogue-line"></div>

        <p>
          Modifications to sample size can be made at an interim analysis in both a blinded and unblinded fashion ...
        </p>

      </div>
			
			
        <a href="/AE" class="catalogue-item">
      <div>
        <h1 class="catalogue-title">Adaptive enrichment</h1> </a>
        <div class="catalogue-line"></div>

        <p>
          Due to treatment heterogeneity, a decision may be made to preferentially enroll specific subsets of patients for reasons of efficacy or safety...
        </p>

      </div>
			
	    <a href="/PE" class="catalogue-item">
      <div>
        <h1 class="catalogue-title">Patient allocation</h1> </a>
        <div class="catalogue-line"></div>

        <p>
         Adaptations may be made based on baseline characteristics or accumulating outcome data...
        </p>

      </div>					
				<p>.</p>
    		</div><!-- /.blurb -->
		</div><!-- /.container -->
		<footer>
    		 <span>
    &copy;  Rebecca Scherzer
  </span>
		</footer>
	</body>
</html>
